强直性脊柱炎患者TNF抑制剂治疗后干扰素相关基因表达变化:一项初步研究
该初步研究纳入26例强直性脊柱炎患者,随机接受TNF抑制剂(n=15)或安慰剂(n=11),分析基线及第22周外周血单个核细胞96个基因表达。发现15个基因(主要为干扰素调节基因)signature可将患者分为四组,ASDAS应答与其中一组独立于治疗相关;TNFi组中12个基因signature与MRI应答相关,另有一IRG signature与TNFi治疗后IRG表达下降相关。血清IL-6下降与BASDAI应答相关。结论提示IRG表达与TNFi应答相关,需更大队列验证。
要点
- 基线15个基因(主要为IRG)signature可将AS患者分组,ASDAS应答与其中一组独立于治疗相关。
- TNFi治疗组中12个基因signature与MRI应答相关,另一IRG signature与治疗后IRG表达下降相关。
- 血清IL-6下降与BASDAI应答相关,提示IRG及细胞因子可能作为TNFi应答生物标志物。
核心结论
- 该初步研究提示强直性脊柱炎患者干扰素调节基因表达与TNF抑制剂治疗应答存在关联。
研究设计与样本
- 研究纳入26例拟接受TNF抑制剂(n=15)或安慰剂(n=11)的强直性脊柱炎患者,于第0周和第22周采集外周血单个核细胞。
- 采用TaqMan assays定量96个基因表达,并用ELISA检测另38例AS患者血清IL-6。
- 应答定义为ASDAS下降≥1.2分或骶髂/椎体MRI病灶减少。
主要发现
- 26例基线样本基因表达分析将患者分为四组,由15个基因(主要为IRG)signature定义,ASDAS应答与其中一组独立于治疗相关。
- TNFi治疗组(n=15)中鉴定出12个基因signature与MRI应答相关。
- 第三个IRG signature与TNFi治疗后IRG表达下降相关(n=10对样本)。
- 循环IL-6下降与BASDAI应答相关。
关键数值与推荐
- 应答定义:ASDAS下降≥1.2分或骶髂/椎体MRI病灶减少。
- 基因表达分析使用TaqMan assays定量96个基因;血清IL-6用ELISA检测。
- 基线15个基因signature将26例患者分为四组;TNFi组12个基因signature与MRI应答相关;第三个IRG signature与治疗后IRG表达下降相关(n=10对)。
临床怎么用
- IRG表达特征可能有助于预测强直性脊柱炎患者对TNF抑制剂的应答,但需更大队列验证后方可用于患者分层。
局限性
- 本研究为初步研究,样本量小(26例基因表达分析,10对治疗后样本), findings需在更大队列中验证以构建预测算法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ankylosing spondylitis (AS) is a chronic inflammatory arthritis primarily affecting the spine and sacroiliac joints. TNF inhibitor (TNFi) drugs are recommended for patients not responding to NSAIDs; however, there is a significant need for biomarkers of response. IFN-regulated genes (IRGs) and other cytokines/chemokines are linked to autoimmune diseases and have been associated with treatment response. Our objective was to explore whether IRGs and cytokines/chemokines can be associated with response to TNFiagents in AS. METHODS: Peripheral blood mononuclear cells were obtained from 26 AS patients who were to receive a TNFi (I, n = 15) or placebo (P, n = 11) at week 0 and week 22. Response (R)/non-response (NR) was defined as reduction in ASDAS ≥ 1.2 points or reduction in sacroiliac/vertebral MRI lesions. The expression of 96 genes was quantified using TaqMan assays. Finally, ELISA was used to measure IL-6 in serum samples from another 38 AS patients. RESULTS: Analysis of gene expression in 26 baseline samples segregated patients into four groups defined by a signature of 15 genes (mainly IRGs). ASDAS response was associated with one group independently of treatment received. We then analysed response to the TNFi (n = 15) and identified a 12-gene signature associated with MRI response. A third IRG signature was also associated with a reduction in IRGs expression post-TNFi samples (n = 10 pairs). Finally, decreased circulating IL-6 was associated with BASDAI-R. CONCLUSION: This pilot study suggests an association between IRG expression and response to TNFi in AS. These findings require validation in a larger cohort in order to construct predictive algorithms for patient stratification.
引用
- Harrison SR, Burska AN, Emery P, et al. Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study. Rheumatology (Oxford). 2021. PMID: 33393636. doi:10.1093/rheumatology/keaa817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。